255 related articles for article (PubMed ID: 15850062)
1. Percutaneous ablation therapy for hepatocellular carcinoma: current practice and future perspectives.
Huo TI; Huang YH; Wu JC
J Chin Med Assoc; 2005 Apr; 68(4):155-9. PubMed ID: 15850062
[TBL] [Abstract][Full Text] [Related]
2. Percutaneous local ablation therapy in small hepatocellular carcinoma.
Lin SM; Lin DY
Chang Gung Med J; 2003 May; 26(5):308-14. PubMed ID: 12934846
[TBL] [Abstract][Full Text] [Related]
3. Outcome of regional and local ablative therapies for hepatocellular carcinoma: a collective review.
Jansen MC; van Hillegersberg R; Chamuleau RA; van Delden OM; Gouma DJ; van Gulik TM
Eur J Surg Oncol; 2005 May; 31(4):331-47. PubMed ID: 15837037
[TBL] [Abstract][Full Text] [Related]
4. Nonsurgical treatment of hepatocellular carcinoma: from percutaneous ethanol injection therapy and percutaneous microwave coagulation therapy to radiofrequency ablation.
Shiina S; Teratani T; Obi S; Hamamura K; Koike Y; Omata M
Oncology; 2002; 62 Suppl 1():64-8. PubMed ID: 11868788
[TBL] [Abstract][Full Text] [Related]
5. Radiofrequency ablation or percutaneous ethanol injection for the treatment of liver tumors.
Ansari D; Andersson R
World J Gastroenterol; 2012 Mar; 18(10):1003-8. PubMed ID: 22416173
[TBL] [Abstract][Full Text] [Related]
6. Population-based matching comparison between radiofrequency ablation and percutaneous ethanol or acetic acid injection for hepatocellular carcinoma.
Chang YJ; Chen LJ; Chang YJ; Chen PD
Eur J Surg Oncol; 2020 Sep; 46(9):1703-1710. PubMed ID: 32475629
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes of radiofrequency ablation, percutaneous alcohol and acetic acid injection for hepatocelullar carcinoma: a meta-analysis.
Germani G; Pleguezuelo M; Gurusamy K; Meyer T; Isgrò G; Burroughs AK
J Hepatol; 2010 Mar; 52(3):380-8. PubMed ID: 20149473
[TBL] [Abstract][Full Text] [Related]
8. Interventional treatments for hepatocellular carcinoma.
Guan YS; Liu Y
Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):495-500. PubMed ID: 17085331
[TBL] [Abstract][Full Text] [Related]
9. Current role of local ablative treatments for hepatocellular carcinoma.
Huang GT; Liang JD; Sheu JC
J Formos Med Assoc; 2004 Jun; 103(6):403-10. PubMed ID: 15278182
[TBL] [Abstract][Full Text] [Related]
10. New applications of ultrasonography: interventional ultrasound.
Solbiati L
Eur J Radiol; 1998 May; 27 Suppl 2():S200-6. PubMed ID: 9652523
[TBL] [Abstract][Full Text] [Related]
11. Radiofrequency ablation for hepatocellular carcinoma.
Nishikawa H; Kimura T; Kita R; Osaki Y
Int J Hyperthermia; 2013 Sep; 29(6):558-68. PubMed ID: 23937321
[TBL] [Abstract][Full Text] [Related]
12. Safety assessment and therapeutic efficacy of percutaneous microwave ablation therapy combined with percutaneous ethanol injection for hepatocellular carcinoma adjacent to the gallbladder.
Huang H; Liang P; Yu XL; Cheng ZG; Han ZY; Yu J; Liu FY
Int J Hyperthermia; 2015 Feb; 31(1):40-7. PubMed ID: 25766386
[TBL] [Abstract][Full Text] [Related]
13. Local ablative therapies in HCC: percutaneous ethanol injection and radiofrequency ablation.
Mahnken AH; Bruners P; Günther RW
Dig Dis; 2009; 27(2):148-56. PubMed ID: 19546553
[TBL] [Abstract][Full Text] [Related]
14. Time-lag performance of radiofrequency ablation after percutaneous ethanol injection for the treatment of hepatocellular carcinoma.
Kurokohchi K; Masaki T; Watanabe S; Nakai S; Deguchi A; Morishita A; Yoneyama H; Ohgi T; Ono M; Yoshitake A; Kako T; Ohmachi N; Kiuchi T; Maeta T; Yoshida M; Mori Y; Kohi F; Kuriyama S
Int J Oncol; 2006 Apr; 28(4):971-6. PubMed ID: 16525648
[TBL] [Abstract][Full Text] [Related]
15. [Less invasive medical therapy for hepatocellular carcinoma].
Ikeda K
Gan To Kagaku Ryoho; 2001 Aug; 28(8):1083-9. PubMed ID: 11525022
[TBL] [Abstract][Full Text] [Related]
16. [Progress of Regional Therapy for Hepatocellular Carcinoma].
Sasaki Y
Gan To Kagaku Ryoho; 2015 Jul; 42(7):771-7. PubMed ID: 26197736
[TBL] [Abstract][Full Text] [Related]
17. Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon's perspective.
Poon RT; Fan ST; Tsang FH; Wong J
Ann Surg; 2002 Apr; 235(4):466-86. PubMed ID: 11923602
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous local ablative therapy for hepatocellular carcinoma: a review and look into the future.
Lau WY; Leung TW; Yu SC; Ho SK
Ann Surg; 2003 Feb; 237(2):171-9. PubMed ID: 12560774
[TBL] [Abstract][Full Text] [Related]
19. Systematic review and meta-analysis of survival and disease recurrence after radiofrequency ablation for hepatocellular carcinoma.
Tiong L; Maddern GJ
Br J Surg; 2011 Sep; 98(9):1210-24. PubMed ID: 21766289
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of transcatheter arterial embolization prior to percutaneous tumor ablation in patients with hepatocellular carcinoma: a randomized controlled trial.
Akamatsu M; Yoshida H; Obi S; Sato S; Koike Y; Fujishima T; Tateishi R; Imamura M; Hamamura K; Teratani T; Shiina S; Ishikawa T; Omata M
Liver Int; 2004 Dec; 24(6):625-9. PubMed ID: 15566514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
